Ligand Pharmaceuticals (LGND) Property, Plant & Equipment (Net) (2010 - 2025)

Ligand Pharmaceuticals (LGND) Property, Plant & Equipment (Net) (2010 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Ligand Pharmaceuticals 5.92 Bn 5.14 Bn 48.45 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 3.47 Mn
Sep 30, 2025 3.47 Mn
Jun 30, 2025 3.63 Mn
Jun 30, 2025 3.63 Mn
Mar 31, 2025 3.62 Mn
Mar 31, 2025 3.62 Mn
Dec 31, 2024 15.13 Mn
Dec 31, 2024 15.13 Mn
Sep 30, 2024 15.09 Mn
Sep 30, 2024 15.09 Mn
Jun 30, 2024 14.97 Mn
Jun 30, 2024 14.97 Mn
Mar 31, 2024 15.14 Mn
Mar 31, 2024 15.14 Mn
Dec 31, 2023 15.61 Mn
Dec 31, 2023 15.61 Mn
Sep 30, 2023 16.18 Mn
Sep 30, 2023 16.18 Mn
Jun 30, 2023 11.38 Mn
Jun 30, 2023 11.38 Mn